Acrivon Therapeutics, Inc.

Develops precision cancer therapies by matching patients to drugs using its proteomics platform.

ACRV | NDAQ

Overview

Corporate Details

ISIN(s):: US0048901096
LEI:
Country:: United States of America
Address:: 480 ARSENAL WAY, SUITE 100, 2472 WATERTOWN
Website:: https://acrivon.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Acrivon Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in precision oncology. The company leverages its proprietary Acrivon Predictive Precision Proteomics (AP3) platform to develop targeted cancer therapies. The AP3 platform utilizes phosphoproteomics to analyze the biologic drivers of a patient's cancer, enabling the creation of predictive 'OncoSignature' tests. This method is designed to match drug candidates with patients whose tumors are most likely to respond, aiming to improve therapeutic outcomes beyond what is achievable with genomics. Acrivon's pipeline is led by ACR-368, a selective kinase inhibitor in Phase 2 clinical trials for various solid tumors. The company also advances its internally developed programs and seeks strategic partnerships to apply its AP3 platform to co-develop predictive tests for external drug candidates.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Acrivon Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Acrivon Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Acrivon Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
i-mobile Co.,Ltd. Operates one of Japan's largest ad networks and a 'Furusato Nozei' tax donation website.	Japan	6535
INBIOGEN CO.,Ltd Data mining, bioinformatics, and virtual assistance for the life sciences industry.	South Korea	101140
Incannex Healthcare Inc. Develops oral cannabinoid/psychedelic therapies for sleep apnea, arthritis & anxiety.	United States of America	IXHL
Incross Co.,Ltd. A digital marketing firm offering data-driven ad solutions via proprietary AI and video platforms.	South Korea	216050
INEST,Inc. Offers ASP solutions and HR support to businesses and sells mobile devices to consumers.	Japan	7111
Innate Pharma Clinical-stage biotech developing NK cell-engaging antibodies for cancer immunotherapy.	France	IPH
Innovation Inc. Drives B2B growth via digital media, IT solutions, M&A advisory, and venture capital.	Japan	3970
Innventure, Inc. Founds, funds, and scales companies using breakthrough R&D from multinational corporations.	United States of America	INV
Inotiv, Inc. CRO providing nonclinical drug discovery, research models, and analytical services for life sciences.	United States of America	NOTV
INTAGE HOLDINGS Inc. Marketing research & business intelligence for consumer goods, healthcare & enterprise tech.	Japan	4326